Course handouts are now available
Click here
Come to London
WATCH to find out why
Site updates:
Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.
Photorefractive keratectomy for extreme myopia
(results will display both Free Papers & Poster)
Session Details
Session Title: Surface Ablations for Correction of Ammetropias
Session Date/Time: Tuesday 16/09/2014 | 08:00-10:30
Paper Time: 08:30
Venue: Auditorium
First Author: : J.Frucht-Pery ISRAEL
Co Author(s): : Z. Caspi D. Landau E. Strassman D. Wajnsztajn
Abstract Details
Purpose:
To report the outcomes of photorefractive surgery (PRK) for extreme myopia in Hadassah Medical Center.
Setting:
Hadassah Medical Center – Hebrew University Hospital, Ophthalmology Department, Jerusalem, Israel
Methods:
We retrospectively reviewed all files of all the patients, who, between January 2009 to December 2012, underwent PRK for high myopia: over -10.00 diopters (D), with a follow-up of 6 months or more (mean 14.70 ±10.05 months). Technolass 217 Z laser was used for PRK. Mitomycin C 0.02% was used intra-operatively for 20 seconds. Principal outcomes were uncorrected and best corrected visual acuity (UCVA and BCVA respectively), refractive spherical equivalent (SEQ) and cylinder.
Results:
One hundred twenty eight eyes of 82 patients (35 males and 47 females) with mean age 27.22±8.92 years were studied. The pre-operative SEQ ranged from -10.00 D to -15.20 D, mean SEQ was -11.26±1.15 D and mean cylinder was -1.27±0.89 D. The post-operative UCVA of 6/6 was achieved in 67% of eyes and of 6/12 in 84.6%. Ninety four percent of all eyes achieved SEQ within ±1.00 D. The safety index was 1.05±0.26. Loss of 2 lines of BCVA occurred in 0.7%. We found moderate haze in 2 cases with visual axis involvement. There were no events of infections or stromal melt.
Conclusions:
PRK for extreme myopia is a safe and efficacious procedure with low rate of complications.
Financial Interest:
NONE